This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover the key Worldwide Dividend ETF Options you should consider for an income-focused portfolio. Learn how to compare dividend yields and risk profiles.
13,773 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Rivian faces a pivotal year as it scales both consumer and commercial EVs amid market volatility. This rivian stock p...
Dlocal is navigating a fast-changing cross-border payments landscape in 2025. This guide breaks down the key drivers,...
When you start taking required minimum distributions (RMDs), a simple mistake can ripple into bigger tax bills, highe...
Chipotle’s stock rebound from a recent malaise is taking shape as pricing discipline and menu changes attract more di...
CFTC staff released a new FAQ detailing how crypto assets can be used as collateral for derivatives, including specif...
A Gold.com board director sold a sizable stake as bullion endured its worst week in decades. This article explains wh...
Trillions moving to heirs may redefine how leaders rise in corporate America. This report explores what the shift cou...
Berkshire Hathaway buying back its own stock marks a notable shift in how the company uses cash. Even a modest repurc...
Oil holds near $103 per barrel as March 2026 unfolds, with supply risks and demand shifts guiding the current price m...
Jet fuel costs are climbing amid geopolitical tensions, prompting United Airlines to warn that airfares could rise as...
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...